The Redox Podcast
By Niko Skievaski
The Redox PodcastDec 16, 2019
#50 Navigating Rapid Cardiology Practice Acquisition with US Heart and Vascular’s Cheryl Rodenfels
To celebrate our 50th episode, we are sharing an internal conversation we had with Cheryl Rodenfels, CIO of US Heart & Vascular (USHV). USHV is a mergers and acquisitions healthcare business working to equip and empower cardiovascular physician practices. Cheryl recently joined one of Redox’s team meetings to share her expertise surrounding M&A in healthcare and the accompanying benefits these have on technology. In her 30+ years of experience, she has held numerous positions in IT and has a mastery of knowledge when it comes to modernizing care. In our conversation, she sheds light on how the industry trend of consolidation benefits practices and why USHV trusts Redox’s product and professional services to support their mission of reengineering healthcare for the better.
#49 Automation’s Impact on the Patient/Provider Relationship with Mytonomy’s Vinay Bhargava
Staff shortages. Clinician burnout. Missed appointments. You’ve seen the headlines – providers and patients alike are struggling with our current healthcare system. What’s the solution?
Last month, Redox’s Niko Skievaski delved into a topical discussion with Vinay Bhargava, president and co-founder of Mytonomy, a patient engagement company with a singular mission: empower people to actively take control of their health. Vinay’s extensive professional journey in consumer technology, passion for digital imaging, and desire to help people navigate complex processes shaped his view of solving some of healthcare’s most pressing problems through a “video-colored lens.” He recognized how his deep understanding of tech could simultaneously improve the patient experience and alleviate clinician burden, which shaped the foundation of what Mytonomy is today.
“We have put our clinicians out for many tours of duty and they need a rest.”
The Mytonomy Cloud for Healthcare enables health systems to reach patients remotely, saving time and valuable resources, while building virtual patient care relationships using award-winning, microlearning video content delivered through an easy-to-use digital engagement platform. Mytonomy is like a “Netflix for healthcare,” enabling healthcare’s digital front door.
“There’s room for optimism in terms of providing access, which is a first step to equity.”
Tune into Episode 49 of the Redox Podcast to hear more from Vinay’s perspective about:
- How automation is easing the burden on frontline workers and patients
- Industry trends and the role of big tech
- Mytonomy’s use cases and enablement of more meaningful patient/provider interactions
#48 Patient Experience & Healthcare's Move to the Cloud with Matt Vestal
Matt Vestal has spent more than 15 years in healthcare technology, and recently joined ConvergeOne to help transform the healthcare arm of their IT and cloud offerings. In our conversation, Matt offers a wealth of insights on the future of cloud strategy in the healthcare space, including his vision for how to modernize the composable patient experience through seamless technology adoption.
#47 Culture 0 to 1 - The People Everywhere Show
Hello Redox podcast listeners! Today’s show will be a bit different. I'm actually sharing a new podcast that focuses on exploring how leaders create thriving workplace cultures in remote teams. It's called The People Everywhere Show and I hope you’ll find this departure interesting and applicable to your own work and life. We launched the podcast today with three episodes right out of the gate. More great episodes are just around the corner. This is an invitation to subscribe to The People Everywhere Show and sign up for our newsletter to stay up to date with the latest episodes.
#46 The Return to HIMSS
Competing conferences, parties, and Niko's mullet. HIMSS is back, and damnit, we’re excited. Redoxers Matt Ripkey and Nick Hatt join the podcast to discuss their expectations for HIMSS, what they’re looking forward to, and tips on surviving the biggest healthcare event of the year.
#45 WebMD’s Ann Bilyew on Why Scale Matters in a Shifting Market
WebMD is usually the resource you run to after noting a random hiccup in your body, but in today’s episode of The Redox Podcast we get to see how WebMD plays a part in the bigger picture of delivering healthcare. Niko chats with Ann Bilyew, the Senior Vice President of Health for Internet Brands, the parent company of WebMD and Medscape. They discuss the organization's recent acquisitions supporting their focus on personalizing the patient experience, how patient strategy is becoming a more consumer-oriented experience, and whether value-based care is inherently competitive with a consumer-focused model.
#44 Extracting Paternalism from the Patient Experience with Kristen Valdes
Kristen Valdes is the founder and CEO of b.well Connected Health. She is a transformative force in today’s healthcare marketplace, spearheading the conversation on how empowering consumers can transform healthcare delivery. With over 20 years in the industry, she lends her insight on paternalism in healthcare, b.well’s vision for the future of healthcare, and the reconciliation of value-based care with the current ecosystem of consumerism.
#43 Olive’s Journey to AI through Robotic Process Automation
Move fast, and fix things. That should be the unofficial mantra of Olive. With nearly $1 billion dollars in funding, they are a dynamo in health tech. In this episode of The Redox Podcast, Olive’s founder and CEO, Sean Lane, takes us on a ride from the visit to his hometown that sparked his hunger for healthcare innovation to the one idea that changed everything. Olive has a big vision for RPA in healthcare, and they plan to get there…fast.
#42 Crashing Primary Care & Dialysis with Dr. Andrew Schutzbank
Dr. Andrew Schutzbank is a Clinical Instructor of Medicine at Harvard, Chief Product Officer at Cricket Health, and was formerly the SVP of Product at Iora Health. We discuss technology adoption and creation in primary care, payment models, business models, and what can be learned in the specialty space, with particular focus in the diabetes world in his work at Cricket.
#41 Epic & Judy's Legacy with Forbes' Katie Jennings
You must have seen the story right? Judy Faulkner, Epic's Founder and CEO took a rare interview with Katie Jennings of Forbes. Long story short, Katie talks with Judy, Niko talks with Katie on this week's episode of the Redox podcast. We get into Epic culture, position in the market, and Judy's perspective on their longterm position in this quickly evolving market.
#40 On the Basics of Pharmaceuticals
Kirk Barnes has spent his career working in the pharmaceutical industry: from drug discovery and development side, to distribution, and, now, aligning digital health strategies with pharma. This isn’t a space I know much about, given its impact in healthcare. Kirk was kind enough to let me get down into the basics around the space and what digital health companies should know as they look to work with pharma companies.
#39 Withings on Remote Patient Monitoring
I'm going to say it, Withings makes the nicest looking smart devices on the market. And now they're coming onto the remote patient monitoring scene in a big way. Antoine Robiliard, Withing's VP of Health Solutions talks with Niko about their RPM strategy and why their experience in engaging patients will give them a huge advantage with, well, engaging patients.
#38 PointClickCare's Evolving Story
PointClickCare has about 70% market share in the long-term and post-acute markets. In the EHR world, this market share is unprecedented. AND, they're cloud-based. They have a truly unique offering and a culture to match. This show features PCC's co-founder and president, Dave Wessinger, along with their SVP/GM, B.J. Boyle. They're interviewed by Redox co-founders Niko Skievaski (president) and Luke Bonney (CEO).
#37 From Buzzword to Buzzer-beater: how SDOH stands to take COVID head on
This week we have the Founder and CEO of Healthify, Manik Bhat. No Niko this week. Our production interns took over for this interview getting into the origins of Healthify as well as the the future of the SDOH space. Q4 being the company’s highest point of growth since their inception, COVID has brought attention to this space, which has sparked both questions and creativity surrounding SDOH’s role in a mid- and post-pandemic world.
#36 Therapy for Kids with Manatee's Dama Dipayana
On today’s show, we have Damayanti Dipayana, the co-founder and CEO of Manatee Health, based in the Mile High city of health tech, Denver, Colorado. We get into the Manatee story and the big splash they made as they launched winning the HLTH pitch competition, Prime Health, and graduating from Techstars. We also get into how Dama manages running an early stage startup with three kids under 4. Truly a herculean feat that she shrugs off as a days work.
#35 A Christmas Carol in Quarantine
As we live through the holidays in quarantine, Niko gets visited by the ghosts of health crises past, present, and future. How did we get here? What can we learn from prior pandemics and vaccine distribution? Are we entering the era of pandemics? Our ghosts, played and written by Rachel Desmond, share these and many more insights, giving us a broad view for our current state of affairs.
#34 Our Social Dilemma: Mental Health in the time of Big Tech with Dr. David Elkin of UMMC
Today on the show we have Dr. David Elkin. He is a pediatric clinical psychologist and founder and executive director of the Center for Advancement of Youth at University of Mississippi Medical Center. The center is a multi-disciplinary approach to coordinated for children with behavioral or developmental issues throughout Mississippi.
I’ve got to say that I really really enjoyed this conversation. We explored how social media/big tech and the pandemic are feeding into mental health issues in our youth as well as the technology being used and contemplated at UMMC to deliver more streamlined mental healthcare.
#33 Regulated consumer health apps with Natural Cycles' CEO (and particle physicist) Elina Berglund, PhD
What does the God particle have in common with the only FDA-cleared birth control app?
The answer: Natural Cycles.
CEO, Dr. Elina Berglund was once a part of the team that found evidence of the media-paraded God Particle, otherwise known as the Higgs Boson. Post this literal Earth-shaking discovery, Dr. Berglund and her team spent the better part of the past decade perfecting an algorithm for a contraceptive app that is 98% effective with perfect use. Beyond impressive. That app is called Natural Cycles. It is the only birth-control app ever to be cleared by the FDA.
In this episode we discuss Dr Berglund’s unique journey into the tech world, the difference between tech people and physicists, and what exactly makes the Higgs Boson such a game changer. Gotta say, it’s the simplest explanation I’ve heard on the topic.
#32 Payal from .406 Ventures on Investing in Healthcare Technology
On today’s show we have Payal Agrawal Divakaran. She leads digital health investments as a partner at .406 Ventures in Boston who was, of course, the first institutional investor to bet on Redox, leading our Series A back in October of 2015. We discuss some of her journey as well as where she’s making (and has made) bets in healthcare technology. This includes Redox, AristaMD, Heartbeat Health, WellbeHealth, and Axial. We also discuss areas where she has an active thesis and is looking for investments.
#31 The Lasting Impact of COVID19 on Healthcare Technology with Terrence Hibbert
We started doing this show back in November 2019, back before the world changed. Then, in March, we got the pandemic that really made everything we were talking about up until that point moot. On today’s show, we’re going to dive into some of those changes.
I invited our early guests on the podcast to make a quick video answering the question: What will be the lasting impact of the pandemic on healthcare technology? We’ll hear from Dr. Bill Hansen, CMIO of UPenn, Jonathan Bush, Executive Chairman of Firefly and founder of athenahealth, Stephanie Tilenius CEO of Vida, Aaron Patzer CEO of Vital, and many more. There are certainly themes that carry throughout, but there are also different messages that are worth discussing and delving deeper into.
So, to help with that delving, I’ve invited an old friend of mine, Terrence Hibbert to hang out with me and talk through some of these predictions. Terrence was most recently the Director of Innovation at University of Mississippi Medical Center. Prior to that, he was the director of IT Solution strategy at UMC.
This show was developed as part of a Redox's Quarterly event and is also available via video. Check it out here: www.redoxengine.com/quarterly
#30 COVID Testing Labs and Electronic Lab Reporting (ELR)
In the near term, rapid and accessible covid testing will be much more important than an actual vaccine. With ample testing, we can identify who’s infected, contact trace, and dramatically reduce the spread. At Redox, we’ve been working with a variety of labs and diagnostic companies who are actively testing patients. I wanted to learn more about how these labs work and how some of them have been stood up so quickly in the wake of the pandemic.
In August, the folks at UCSD reached out to us about a new covid testing clinical lab they were standing up. By September, we had integrated the UCSD Biochemical Genetics Excite Lab’s information system with Epic, their EHR. I invited on of the masterminds behind its creation, Dr. Louise Laurent, on the show today to share the story of how they stood up their lab so quickly and scaled it to 1000 tests per day in just a few months. Covid time flies.
We’re now working with UCSD on electronic lab reporting to share these results with the appropriate public health agencies. In the pandemic, Redox has gotten really good at ELR and it’s something that we get asked about daily. So with that in mind, I invited Meredith Haley, customer success at Redox who leads the team who works with these customers, to give us the quick rundown on the ELR space.
Dr. Louise Laurent is a Professor and vice chair for translational research at the University of California San Diego. She’s both a researcher (focused on applying genomic and epigenetic methods to optimize the clinical and preclinical utility of stem cells), as well as an OB-GYN physician caring for women with high risk pregnancies.
Beyond these responsibilities, she’s spent the past many months utilizing these skills to co-create a high throughput covid testing pipeline and the UCSD Biochemical Genetics Excite Lab that’s now serving all of the UCSD’s students and faculty as part of their Return to Learn initiative. I invited her here today to tell this story as both a bright spot in our health care system’s response to the pandemic as well as an example to other similar organizations attempting to do the same.
Highlights:
- 02:39 - How the USCD Biochemical Genetics Excite Lab got started
- 07:27 - From sample to result, the testing workflow
- 09:28 - Overview of Electronic Lab Reporting (ELR)
- 13:22 - Redox’s approach to ELR
- 18:58 - Observed vs unobserved sample collection
#29 Vida on Virtual Chronic Care and Mental Health
Looking back at 2020, we might say that this was the year that changed everything in healthcare. If that’s the case, Vida will have likely played a big role in this change. They’re focused on some of the most costly areas of healthcare in chronic care management and mental health. And, they sell to payers and employers who, with incentives to keep patients out of costly situations, are playing a bigger and bigger role in actual patient care.
My guest today is Stephanie Tilenius, the founder and CEO of Vida Health. She founded Vida in January of 2014 (right around the same time as Redox, by the way) after a storied career in silicon valley having worked at eBay, PayPal, Google, and as an executive in residence at Kleiner Perkins. Since then, Vida has raised $83M including a recent $25m round in April and has, according to LinkedIn, nearly 500 employees. Vida is a mobile continuous care platform for preventing, managing and overcoming chronic and mental health conditions deployed at Fortune 500 companies and large national payers.
We were able to talk a bit about how Vida actually interacts with patients and changes their behavior, some of their outcomes, and the shifting dynamics in the industry. Big thanks to Stephanie for coming on the show as well as to everyone at Vida for making healthcare a little bit better.
Highlights:
- 01:22 - How and why Stephanie went from consumer products to healthcare
- 05:49 - Onboarding and triaging users
- 08:16 - Mental health and chronic conditions are tied together
- 11:38 - Measuring outcomes at Vida
- 14:30 - Selling into the payer space
- 16:18 - Since COVID, payers have increased demand for digital health
- 18:13 - Telehealth reimbursement parody discussed
- 19:20 - Vida’s $25M latest round of funding
- 21:14 - How payers are shifting towards value based care
- 26:10 - Potential channel conflicts with community providers
#28 Getting paid with Medicaid in THIS economy
Rachel Dixon is an expert in the clinical, operational, and technological implementation of telehealth and other innovative digital health solutions in Medicaid-focused organizations. Rachel has worked across the spectrum of care, successfully designing and implementing programs on behalf of payers, primary care providers, mental health centers, and more. In addition to being the President of Prime Health, Rachel serves Colorado as an eHealth Commissioner.
We discussed various opportunities and strategies for healthcare startups working with the government as well as how telehealth has evolved in Colorado and beyond.
- 2:10 - Colorado’s COVID-19 telehealth response
- 7:30 - How vendors should collaborate with public health programs
- 11:00 - Getting started working with the government
- 19:27 - Examples of startups getting government funding
- 20:23 - The future of telehealth parody reimbursement
- 26:46 - Examining the business of telehealth for large health systems
- 32:06 - The Prime Health Challenge (link to program)
- 39:53 - Prime Health Innovation Summit (link to event)
Shift+6: Greg@Propeller Health
I've known Greg Tracy since before founding Redox, connecting over civic hacking projects in Madison, Wisconsin. As the co-founder and CTO, Greg helped Propeller Health from its inception to serving patients across the globe and through its recent acquisition by ResMed (for $225M), where he now serves as the chief architect.
Greg shares the Propeller Health story, their early choice to go through FDA clearance, and how they built the business into a global brand, as well as the constant struggle to prioritize projects, no matter how large the organization. He’s always been a mentor to the up and coming developer-leaders in Madison; this conversation exemplifies this. Thanks for the great conversation Greg!
- 1:12 Overview of Propeller Health’s product offering
- 3:09 Greg’s background and starting Propeller
- 8:29 Balancing speed and quality in an FDA certified domain
- 11:57 Managing a diverse set of users and stakeholders
- 14:29 “Suck” meetings for engineering
- 16:59 Getting acquired by a public company
- 23:24 Prioritizing endless wants
- 27:19 How Slack fails product teams
- 30:00 The best innovation in healthcare comes from those without experience
Find Greg on Twitter (@GregTracy).
#27 Nikita, Nikhil, and Niko
Nikita Singareddy and Nikhil Krishnan joined me on the show this week. You don’t often hear their last names as these two have rapidly earned their way into the ranks of first-name status in our industry. I wanted to have both of them on the show together as they have incredible rapport and both bring an absolutely refreshing and unique perspective on the industry, as younger analysts having graduated college in ‘16 and ’14.
Nikita (@singareddynm) is the creator of the Waiting Room blog. Her recent coverage of the new interoperability regulations is one of the best out there. In her day job, she’s an investor at RRE Ventures. She cut her teeth in healthcare working at Oscar Health.
Nikhil (@nikillinit) is the creator of the Out-Of-Pocket blog. He brings a satirical slant to his coverage of more esoteric slices of our industry, employing memes throughout to shine a light on the ridiculousness of the various arrangements he uncovers.
The conversation jumps around a bit and they end up making my job really easy, interviewing each other on how they met, industry trends, how they got into the space, and tips for young people trying to do the same. Here are some highlights:
2:51 - Nikhil’s background avoiding healthcare, then ending up here
5:04 - Tips for people breaking into healthcare
6:56 - What will change as Millennials and GenZ emerge
11:18 - Creating a safe environment for creative courage
13:34 - Here’s the Venture Stories podcast Nikita mentions
17:13 - Nikita’s journey from Oscar to RRE
19:28 - Current industry trends driving Nikhil’s and Nikita’s investments
28:33 - How consumers are poised to upend existing business models
35:15 - Nikita’s thoughts on her next job
37:46 - Nikhil’s vision for Out-Of-Pocket
Hope you enjoyed the conversation. As always, send any feedback, suggestions, ideas to podcast@redoxengine.com.
Shift+6: Danielle@Broad Institute
Today’s guest is Danielle Ciofani. A data architect turned strategist, she leads the Broad Institute’s Data Sciences Platform team maximizing the impact of data science on the biomedical ecosystem. She also cares deeply about the startup community and serves as a mentor to early-stage companies at the intersection of healthcare and data.
Prior to these roles, Danielle designed, built, and grew the largest integrated real-world database of clinical and claims data at Humdecia which was eventually acquired by Optum.
I really enjoyed this conversation. I learned about how the Broad Institute (pronounced “brode”) enables genomic research (1:11) and how they manage that much data via a hybrid cloud strategy (11:20). I found their reasoning behind their decision to utilize GCP (13:58) fascinating. They’re at a point where building a federated multi-cloud architecture (17:18) spanning AWS and Azure is starting to make sense. We discussed infrastructure considerations for international expansion (22:23) and how personalized medicine can combat institutional biases (24:33) to create more equitable healthcare delivery.
Danielle shares her take on the state of our healthcare system as it shifts under the weight of the pandemic (28:56) and why diversity in building teams (31:51) is so important. We get into what it means to build open-source software (34:08). Finally, Danielle shares resources to dive into for folks getting into the space (39:52).
If you’re interested in reaching out to her, find her on linkedin or her website.
Danielle, thank you so much for spending your time with us on the show!
#26 The State of Interoperability in 2020 with Redox's Brendan Keeler
Before 2020 spiraled into pandemic, social, economic, and political unrest, I expected interoperability to be the hottest topic in healthcare. There are a number of reasons for this.
- Consumers became unruly, asking simple questions like “in this modern era, why can’t my specialist see my electronic health record?”
- Providers and health systems have attempted to adopt modern digital health tools, but have found difficulty in integrating these tools with their legacy EHR systems.
In response to these industry-wide problems, and without a private-sector path forward, the federal government released sweeping, and some would say “heavy-handed”, set of interoperability regulations designed to create the appropriate rules and incentives to solve these problems. These regulations are rooted in Biden’s 21st Century Cures Bill, passed at the end of the Obama administration. But the actual rules and enforcement were introduced in Trump’s. This unprecedented bi-partisanship tells us at least one thing: the government has lost faith in EHR vendors and the health systems and providers that use them, to solve it on their own.
Today’s show is the first of our second season of the Redox podcast. I thought it’d be a good time to unpack the word interoperability. This concept in healthcare has more depth, history, and complexity than syllables. So why is it such a big deal? How did we get to this place? And why did the government feel the need to step in?
To help me with the unpacking, I invited my friend and colleague, Brendan Keeler to join us. Brendan is a product leader at Redox, helping to translate industry demand into Redox supply. Before Redox, Brendan worked on interoperability at Epic both domestically and internationally. I’ve found his views on the space to be particularly insightful and concise, and lean on him constantly as I grapple with emerging trends.
Highlights from the conversation:
- 2:27 - Three types of interop: Integration, Enterprise Interoperability, Patient Auth
- 7:11 - Common standards used for each type of interoperability (HL7v2, C-CDA, FHIR)
- 11:50 - Will FHIR start to replace other interoperability standards
- 15:14 - The regulatory push towards ubiquitous use of FHIR
- 19:03 - Why banking didn’t need the same regulatory pressure
- 23:51 - If we want ubiquitous adoption of FHIR, we should have penalized the use of HL7v2
- 26:12 - How the Big Fax will forever hold back innovation in US healthcare
- 27:06 - Takeaways on interoperability for developers, providers, patients, and integration analysts
Brendan, you’re the man. Thanks for joining the show and sharing your take on the current state of interoperability in healthcare. Find Brendan and continue the conversation on Twitter: @healthbjk. He’s a great follow.
If you liked today’s show music, we’ve got to thank Redox’s very own Stephen Herrera who gave up what would have been a prosperous career as a DJ to join our operations team.
Shift+6: Ryan@Folx
We’re thrilled to announce Shift+6, a developer-focused, health-tech podcast from Redox. Here we'll explore the ways amazing technologists are bringing new innovation to market, growing their teams, and dealing with an ever-changing landscape in one of the world's most complex industries.
We believe that technology from diverse and empathetic creators holds the power to improve the lives of patients across the globe. And we hope this podcast helps make your work in healthcare even more impactful.
Our first guest is Ryan Scharer, the CTO of a new (and maybe in stealth mode?) telehealth startup called Folx. You might be wondering, “Does the world really need another telehealth offering?” Short answer: yes, this world does. Folx is aimed at LGBTQ+ communities with representative care providers, “Telehealth that’s pretty queer” as their website states. Check out their purpose statement here, it’s moving.
Ryan’s building on a long history of success in the digital health space, having played this early-stage engineering lead role at Humedica (acquired by Optum) and PatientPing. We dive into those early decisions and tradeoffs we make in building product and eventually taking it to scale. Here are some highlights:
- 2:00 - Ryan pitches Folx
- 4:33 - unique features, based on this demographic
- 6:07 - contrasting more established digital health with early-stage startups
- 8:53 - new technologies Ryan’s excited about
- 13:10 - balancing moving fast, or building things for scale
- 17:33 - the benefits of experience in getting started
- 20:34 - choosing an EHR
- 29:45 - resources for getting started in health tech
Ryan mentioned to reach out to him on LinkedIn if you have questions or want to start a conversation.
Thanks for tuning into our first episode of Shift+6. We’ll be launching our own podcast show soon so look out for that and be sure to subscribe. And let me know if you have ideas or feedback for the show. We’re excited to bring this to the healthcare developer community.
#25 eConsults and coping with the year 2020 with Gil Addo of RubiconMD
Gil Addo is the co-founder and CEO of RubiconMD, the leading eConsults platform connecting primary care to specialists around the country.
I've known Gil for years and have always felt a kinship of sorts with him as I feel like we came from the same era of health tech startups, seeing him over and over again at similar early-stage digital health events around the country. Our conversation dives into his business quite a bit and explores factors in the changing healthcare landscape like value-based care, new primary care delivery models, and systemic racism in society and our industry.
Key Moments:
01:54 - What does RubiconMD do?
08:12 - RubiconMD’s startup story
11:19 - How they solved the chicken or egg problem
14:24 - Emerging primary care models
17:09 - Pandemic-caused changes
27:07 - Are we still moving towards value-based care?
30:43 - Gil’s optimist view on systemic racism
34:40 - Shield implicit bias in specialty consults
36:40 - The future for RubiconMD
Thanks again to Gil and the whole team at RubiconMD for the work they do. Find Gil on Twitter, LinkedIn, or RubiconMD’s website.
#24 The Digital Episode of Care with Bronwyn Spira of Force Therapeutics
It’s an honor to have Bronwyn Spira, CEO of Force Therapeutics, on the show today. Force is a leading episode-based digital care platform and is also one of Redox’s first customers from back in 2015. We were able to catch up on what they’re seeing in the marketplace including how the pandemic has affected the world of episodic care that they primarily operate within.
Key Moments:
02:00 - Force’s customers (NYU, Geisinger, Muve Health, Northwell, etc.) and what they do for them
09:25 - The importance of a clinical team
10:32 - Being in NYC for the pandemic and a Redox pizza party
14:02 - A VIRTUAL Escape Room?! (link here, thanks Rachel!)
15:29 - Standing up telehealth in one week
20:42 - Telehealth as a commoditized feature
22:03 - How do you digitize something so physical?
27:58 - Utilizing data for clinical research
34:43 - Collaborating with academics and AI for customized care plans
37:21 - A Redox commercial from Bronwyn ;)
I think they’re a great example of how to build a multi-sided platform in healthcare. They were able to take advantage of regulatory tailwinds with the move to bundles to find early footing, then listen to their customers and patients to drive more value and engagement, then leveraged their data asset to contribute to research and improve their product experience by creating customized data-driven care plans. I’ve heard many many entrepreneurs pitch these sorts of stories but it’s far more rare—especially in healthcare—to see them fulfilled. Thanks again Bronwyn, for being on the show, for being a customer, and for the work you do to improve patient outcomes every day.
-Niko Skievaski
#23 Preventing Sepsis with Luminare’s Dr. Sarma Velamuri
Dr. Sarma Velamuri is an Internal Medicine doc, hospitalist, sepsis expert, and co-founder and CEO of Luminare, a company focused on the early detection of sepsis. On this episode, we dive into sepsis detection and prevention, as well as how these systems can work to help prevent the spread of other viral infections, like COVID-19.
Key Moments
- 01:39 How sepsis came to the forefront
- 03:33 Luminare’s tragic founding story
- 06:35 Alarm fatigue in EHRs and how to overcome it with workflow design
- 08:54 Luminare’s impact and value proposition
- 10:56 EHR integration with Redox*
- 13:07 Pivoting for pandemic response
- 15:39 Employers utilizing Luminare to screen employees for work
- 18:03 On safely reopening the economy
*Full disclosure, Luminare is a Redox customer and it gets a little commercially in there for a minute. ;)
I find Luminare as a great example of a physician-founded startup doing it right, solving the problem through a focus on workflows and market demand. Big thanks to Sarma for taking the time to share his story. Enjoy!
#22 COVID's Impact on Redox and Digital Health
On Tuesday, we had to layoff 44 Redoxers. That was about 25% of our team. On today's episode, we're going to go into the conditions that brought us to this place, how we went about making the decision to reduce the size of the team, and finally how we attach names to that decision.
Redox co-founders Luke Bonney (CEO) and Niko Skievaski (President) are joined by board member Raju Rishi. Raju is a general partner at VC firm RRE Ventures and led Redox's series B in January of 2017. Beyond sharing his perspective on the market and the layoffs he offers some relevant stories from his days as a founder. We thought sharing what we're going through might be helpful as I know a lot of people in our industry are attempting to figure out how to navigate the waters through recovery.
Additionally, Redox is working to place these 44 people at jobs within the industry. Contact christine@redoxengine.com to learn more.
#21 The Economics of a Healthcare Recovery with Berkeley’s James Robinson
Professor James Robinson is a highly-regarded expert on health care economics and policy. He is currently a Professor of Health Economics at the University of California, Berkeley and Director of the Berkeley Center for Health Technology. Dr. Robinson is also on the board of the Integrated Healthcare Association (IHA) and the National Institute for Healthcare Management (NIHCM). He has published three books and over 140 papers in peer-reviewed journals such as the New England Journal of Medicine and JAMA. He is also the former Editor-in-Chief of Health Affairs. Dr. Robinson’s book, “Purchasing Medical Innovation: The Right Technology for the Right Patient at the Right Price,” examined the roles of the FDA, health insurers, hospitals, and consumers in the assessment, purchasing and use of high-cost implantable devices.In this spirited conversation with Niko Skievaski, Dr. Robinson offers his insights into the current economic outlook for providers, hospitals, payers and patients - as well as a peek at what the post COVID-19 world might look like. You’ll enjoy the discussion.
Here are some of the highlights:
03:43 - “Anybody that talks about a V-shaped recovery is completely out of their mind.”
06:37 - The number of people with employee-based insurance is going to continue to drop.
11:12 - The impact of the pandemic on the business of healthcare.
13:59 - Lessons from the pandemic: Excess capacity and duplication are IN! Lean and global supply chains are OUT!
16:42 - “Most of what goes under the name of value-based care is just marketing!”
22:34 - The enormous impact of social determinants on health care.
29:30 - Looking at some of the positives ahead.
Dr. Robinson is not shy about sharing his opinions, as well as his prescriptions for an improved economic outlook for the U.S. healthcare system. Our thanks to James Robinson for a thought-provoking edition of the Redox Podcast.
#20 “Powered by Battery” with Redox CEO Luke Bonney
Redox CEO Luke Bonney was the featured guest on this week’s episode of Battery Venture’s “Powered by Battery” podcast series. The wide-ranging conversation covers everything from the company’s start as a digital-health incubator in Madison, Wisc. to its current position as an indispensable data exchange platform utilized by healthcare companies of all sizes. Luke also explains the creative ways that customers are using Redox to help in the fight against COVID-19.
02:42 - Redox’s roots; from Madison, WI start-up to remote digital healthcare innovator
06:01 - The need for scaling data integration for Cloud-based applications
08:31 - Helping customers deal with COVID-19
10:39 - How Redox powers telehealth applications
14:25 - Keeping Redoxers connected, informed and well during COVD-19 - personally and professionally
18:45 - Luke’s four priorities as Redox CEO
21:29 - The biggest unknown today is the economic impact caused by COVID-19 on American healthcare
25:50 - Policy creating tailwinds for interconnected healthcare
28:42 - Three things keeping Luke sane during COVID-19 - family, exercise and relationships
30:51 - The importance of surrounding yourself with the right people
For more great investor insights, be sure to visit the “Powered by Battery” blog and podcast series.
#19 The New World of Telehealth with Dr. Sylvia Romm
Dr. Sylvia Romm is the chief innovation officer at Atlantic Health System, a 7-hospital organization based in northern New Jersey. A senior pediatrics resident at Harvard, Dr. Romm previously served as VP of Clinical Transformation with AmWell. She is also a highly-regarded author and speaker on topics related to healthcare, technology and health IT policy. Dr. Romm is driven by an entrepreneurial spirit and a passion for transforming healthcare delivery. She recently spent time talking with a former colleague and friend, Redox’s Chief Customer Officer Elif Eracar.
Here are some of the highlights from this fun and insightful interview:
02:15 - Dr. Romm’s journey from pediatric hospitalist to telehealth innovator
04:25 - From starting MilkOnTap to AmWell
07:01 - Advantages and challenges of virtual health providers
10:10 - Telehealth’s ability to mitigate physician burnout
13:50 - Current state of value-based care
16:38 - The importance of making healthcare easily understood
19:48 - How COVID-19 has impacted the trajectory of telehealth
23:14 - Telehealth as a career option
Our thanks to Dr. Sylvia Romm of Atlantic Health System for sharing her insights with us. Telehealth is destined to become an integral part of the healthcare experience in the years ahead - and leaders like Dr. Romm are leading the way. Thank you for listening to the Redox Podcast.
#18 Platforms in Healthcare - Part 2
Welcome to Part 2 of our discussion of Platforms in Healthcare. I was pleased to be joined by:
Anurati Mathur, CEO of Sempre Health
Carlo Perez, CEO of Swift Medical
Dr. Mitesh Rao, CEO of OMNY Health
Niko Skieavski, President of Redox
Seth Joseph, managing director of Summit Health, served as our moderator.
This portion starts with ideas on how to tackle the chicken or egg problem, the concept of viral growth, and how to finance platform operations. Finally, we tackle the problem of what makes healthcare so different for those launching multi-platform businesses.
01:36 – Carlo Perez explains how Swift tackled the issue of building a multi-sided platform
04:55 – Niko on starting by adding real value to one side
07:39 – Sempre’s rationale for focusing on the payer side at the outset
11:55 – Leveraging early adopters to gain experience and credibility
16:20 - Financing multi-sided platforms
21:46 – Lessons learned by these entrepreneurs.
Our thanks to Seth, Anurati, Carlo, and Mitesh for sharing their experiences and opinions. These are some of the creative and passionate people that are working hard every day to change healthcare for the better. We look forward to watching their companies grow in the months and years ahead. Thank you for listening to the Redox Podcast.
#17 Platforms in Healthcare - Part 1
Redox is an example of a platform business model in healthcare. We connect healthcare organizations and software vendors with reusable technology, thus creating a scalable network of data exchange. In addition to Redox, there are a number of other really innovative companies using platform business models to solve major challenges in healthcare. The opportunities to make a positive difference in how healthcare is delivered are exciting, but the challenges are numerous. So a number of us decided to get together to share experiences and ideas. Our guests for this two-part program include:
Anurati Mathur, CEO of Sempre Health
Carlo Perez, CEO of Swift Medical
Dr. Mitesh Rao, CEO of OMNY Health
Niko Skievaski, President of Redox
And I was pleased to have Seth Joseph, managing director of Summit Health, join us as moderator. Previously, Seth was head of corporate strategy for Surescripts, one of the few nationally scaled multi-sided platform businesses in healthcare. Surescripts is now processing 19 billion clinical transactions a year. In the first episode, we examine multi-sided platforms, networks, and their business models. Some of the highlights from Part 1 include:
03:00 – Niko and Seth provide background on platform businesses
06:50 – The Surescripts experience
13:35 – How OMNY creates value for users
16:08 – Sempre Health’s approach
18:58 – Which side of the market should be charged?
23:49 – Anurati discusses incentive alignment
28:15 – Swift’s rigorous credentialing process
#16 Dr. Roxie Mooney's advice for health tech start-ups
Dr. Roxie Mooney is CEO & Healthcare Innovation Strategist of Legacy DNA, a company that helps health innovators move from idea to full market adoption. Legacy DNA is known for its COIQ System - which is a mash-up of the acronym COI, “commercialization of innovation,” with IQ. COIQ represents the knowledge and insights that health innovators need to maximize market success. Over the past 20 years, Dr. Roxie has helped to generate marketplace success for a wide range of health and lifestyle companies. She generously shared her insights with Niko Skievaski in this conversation.
Here are some of the highlights:
02:35 – Being creative and helpful during COVID-19
07:25 – Building an early adoption strategy
15:35 – How to avoid “pilot purgatory”
20:18 – The role health systems play in helping innovators come to market – for better or worse
25:43 – Changes for technology developers as they cope with changing sales cycles
31:40 – What can start-ups do to stay viable during the current economic disruption?
Our thanks to Dr. Roxie Mooney for sharing her expertise with us on The Redox Podcast.
#15 Our new COVID-19 world with Greenway's Dr. Geeta Nayyar
With COVID-19 dominating world events, Dr. Geeta Nayyar generously shared her time, insights and advice with Niko Skievaski. Doctor Nayyar is the chief medical officer for Greenway Health and a nationally recognized leader in health information technology. Prior to joining Greenway, she held positions as chief healthcare and innovation officer at Femwell Group Health and CMIO at AT&T. In addition to her business responsibilities, Dr. Nayyar is a practicing rheumatologist and maintains faculty affiliation with the University of Miami, where she teaches at the medical school. Doctor Nayyar is the author of the mobile health chapter in the HIMSS Medical Informatics textbook and is a six-time HIMSS Digital Influencer.
The conversation is fascinating from start to finish – here are a few chapter sections.
02:12 – COVID-19 has changed things for everyone.
12:18 – Where is technology’s place in this pandemic?
16:46 – When will the curve be flattened?
18:44 – How long might this last?
25:19 – We didn’t do a good job of translating the problem.
26:20 – Pay attention to Dr. Fauci and the CDC guidelines.
31:36 – Social distancing activities
It is astonishing to witness the skill and selfless commitment of healthcare workers around the world as they fight every day to provide the best possible care for their patients during these gut-wrenching days.
Our thanks to Dr. Geeta Nayyar for sharing her expertise with us on The Redox Podcast.
#14 COVID-19: Can Digital Health Help?
We're in the midst of a worldwide pandemic that will strain our healthcare delivery system beyond anything we've seen before. Those of us who work in healthcare technology have reprioritized to attempt to bring something novel--something of use--to the new challenges faced by health systems. This is a special episode of the podcast including guests from 10 digital health vendors who have created a COVID-19 specific solution. From the time a patient thinks they have symptoms, to getting on a waiting list, to triaging in an overcrowded and socially-distant emergency department, to care within the hospital and beyond, digital health solutions have stepped up to fight this pandemic.
1:15 - Social distancing and the excess demand problem
3:26 - Hypothesis: technology can be used to increase caregiver efficiency and effectiveness
6:02 - Vital and c19check.com screening tool
9:00 - Epion's remote check-in and triage solution
11:13 - Gauss and Operation Apollo for contactless triage
14:35 - ER Express's virtual waiting room
16:14 - Bravado and the forgotten patient population
18:09 - Redivus reducing errors in cardiac arrest
22:00 - EmOpti's streamlined telehealth triage
26:19 - CareLoop in reducing PPE and better communication
32:22 - Logical C19 Tracker for remote patient monitoring
35:02 - MedBridge's COVID-19 patient and provider education tool kit
We adopted these tracks from our 3/25 virtual conference: Innovate COVID. Check out our COVID-19 resource center for more solutions and videos from the conference.
#13 The Walking Gallery with Regina Holliday
Fred Holliday was diagnosed with metastatic kidney cancer in 2010. At one point, his wife Regina asked to see Fred’s medical records. Fred and Regina were astonished by what they experienced – how difficult, and in some cases impossible, it was to access crucial personal health data. Fred passed away in mid-June of that year, at only 39 years old. In one of his final messages, he passed a handwritten note to his wife that read, “Go After Them Regina, Love Fred.”As an artist, Regina was able to express her grief and frustration through her paintings. She was invited to create a mural on the back of a gas station on Connecticut Avenue in Washington, DC. She titled the piece “73 Cents,” because that was the quoted price per page for Fred’s paper medical record. Less than a month after beginning the mural, Regina was talking to members of the US Senate and to reporters around the world. The painting, which can still be seen today in the nation’s capital, helped make patient access to data become a core measure in the Meaningful Use legislation in 2010. From this tragic experience was born “The Walking Gallery.” After the mural became widely known, Regina began painting patient and family stories on the back of jackets and blazers. These stories often come from a place of deep pain; such as the death of a loved one or a chronic condition that they a patient battles every day.
There are now 466 members wearing jackets painted by 52 artists. Regina herself has painted over 400 jackets! At HIMSS20 next week - and other healthcare events - you’ll see members of the Walking Gallery strolling around the conference.
Niko Skievaski spoke with Regina Holliday about the Walking Gallery and her ongoing quest to ensure patients and families can access data when they need it.
02:11 – Regina’s shocking experience trying to access her husband’s patient data
04:38 – The “horrific” conditions fueled her advocacy
06:22 – An AMA meeting attendee asks for a painted jacket – the start of the Walking Gallery
10:40 – Having access to data is empowering for the patient
18:51 – The “ripple” impact of the Walking Gallery
21:07 – How can people get a painted jacket?
23:32 – If you see someone wearing a Walking Gallery jacket, feel free to ask the person their story
Regina Holliday travels the globe spreading her message of patient empowerment and inclusion in healthcare decision making. Our thanks to Regina for sharing her story on The Redox Podcast.
#12 What's with the Pink Socks?
Pink Socks Life is a nonprofit organization focused on promoting human connection around the world by socially supporting other public charities. If you have been to a health tech conference in the last five years, you’ve likely seen people wearing pinksocks with mustaches on them. Well, the movement began – somewhat accidentally – at the HIMSS conference in 2015.
Today, this community of over 100,000 happy smiley people are united in working to change the world from the ground up – with heart speak, hugs, and gifting. As HIMSS20 draws near, Niko Skievaski chatted with the founders of pinksocks – Nick Adkins and Andrew Richards.
01:30 – The accidental start of pinksocks
05:43 – Creating a shared cultural narrative
11:12 – How the “gifting” ethos at Burning Man struck a nerve with Nick
15:40 – Expanding from healthcare into education
20:30 – Additional charities that pinksocks works with
27:15 – How to get involved with the pinksocks movement
32:15 – Description of the pinksocks blog, which chronicles how pinksocks has impacted lives around the world
The pinksocks movement has grown from healthcare into all kinds of industries around the world. And, as stated on the pinksocks website – “The pinksocks are our reminder that shared connection is what it’s all about. Have fun! Smile! Give hugs! Life, it’s happening right now! Don’t miss it!”Our thanks to Nick Adkins and Andrew Richards for joining us on The Redox Podcast – and, more importantly, for spreading kindness through Pinksocks Life.
#11 HIMSS20 Preview
The HIMSS20 Global Health Conference takes place next week in Orlando. Participants from all corners of the industry – from vendors, clinicians and health system executives to policymakers and patient advocates – will get together to learn, share ideas and socialize. The enormity of the conference – nearly 45,000 professionals from more than 90 countries – can be overwhelming. Niko Skievaski had the chance to catch up with three long-time HIMSS participants who were happy to share their perspective on what to expect and how best to navigate HIMSS. This lively and informative conversation includes:
Lygeia Ricciardi, chief transformation officer at Carium and former ONC official (https://twitter.com/lygeia)
John Lynn, founder of HealthcareScene.com (https://twitter.com/techguy)
Colin Hung, editor of Healthcarescene.com (https://twitter.com/colin_hung)
Here are some of the highlights from their conversation:
02:28 – Most memorable HIMSS experiences
07:32 – Top three things experts are looking for at HIMSS20
13:06 – Thoughts on the pending ONC rules
20:20 – The role of Big Tech in healthcare
26:25 – Advice for navigating HIMSS20
While concerns about the coronavirus may impact the travel plans of some, HIMSS20 is slated to take place as scheduled and we expect it to be another massive event – one that spreads knowledge, creates relationships, and sparks innovation. Our thanks to Carium’s Lygeia Ricciardi and Colin Hung and John Lynn of Healthcare IT Today for joining us on The Redox Podcast.
#10 Improving access to care with Roundtrip's Ankit Mathur
At Redox, we might have a bit of a startup crush on Roundtrip. But that’s easy when you work with such impactful companies. Every day, 10,000 patients miss or delay necessary health care due to a lack of proper transportation. The cost to the United States healthcare system last year because of missed medical appointments and unfulfilled prescriptions was a staggering $150 billion.
But this problem goes way beyond dollars and cents. The greater concern is the health of millions of patients who aren’t getting the care and medication they need – simply because they don’t have a ride. In 2016, Ankit Mathur, Angela Damiano, and Mark Switaj banded together to design a ride ordering solution that improves access to care. The company they founded is Roundtrip. Ankit, Roundtrip’s chief technology officer, recently sat down with me to share their story.
Here are some of the highlights from their conversation.
01:55 – How Roundtrip got started
04:41 – Getting a multi-sided network off the ground
09:25 – Roundtrip’s early milestones
19:09 – Attracting providers, patients and transportation services to participate
27:45 – The importance of value-based care
35:15 – How the network effect propels Roundtrip’s go-to-market strategy
38:27 – What’s ahead for Roundtrip?
Roundtrip is making a significant difference in the quality of care for patients. MedCity just reported that they’re saving Contra Costa 25% over taxi and bus vouchers, in preliminary results. We look forward to watching the company grow in the years ahead. Our thanks to Ankit Mathur for joining us on The Redox Podcast.
#9 The Mint.com for health with Aaron Patzer from Vital (and founder of Mint.com)
Aaron Patzer is founder and CEO of Vital, AI-powered software for hospital emergency rooms and patients. As an entrepreneur, Aaron has had success at a number of companies, most notably the ground-breaking Mint.com – which he founded in 2006 and eventually sold to Intuit. The success of Mint.com shook up the financial services industry and paved the way for other innovators, including Plaid, the platform that enables applications to connect with users’ bank accounts (Visa acquired Plaid for $5.3 billion in 2020). Last year, Aaron launched Vital to bring a similar consumer-focused mindset to emergency rooms and hospitals.
However, as you’ll hear in this fascinating conversation between Aaron and Niko Skievaski, creating “a Mint.com for the healthcare industry” is not an easy task. There are significant differences and obstacles to be addressed. But these two innovators are confident that transformation is coming. Listen on…Here are some of the leading topics.
02:31 – How Mint.com came to be
10:40 – Why isn’t there a Mint.com yet for healthcare?
17:02 – Applying the lessons learned at Mint.com to healthcare
23:10 – What is “adversarial interoperability?”
26:43 – A bit about Vital
37:08 – Enabling providers with the right information at the right time so they can provide the best care
46:55 – Powering applications that make a difference
Aaron Patzer was one of the major figures responsible for disrupting the enormous personal finance market. We’re anxious to see the results of his foray now into digital healthcare. Our thanks to Aaron Patzer for joining us on The Redox Podcast.
#8 Healthcare Data Privacy Rights with Attorney Matthew Fisher
With HIMSS 2020 coming up soon, Niko Skievaski spent some time chatting with Attorney Matthew Fisher, a partner at the law firm of Mirick O’Connell in Westborough, Massachusetts. Matt is the chair of the firm’s Health Law Group and one of the HIMSS top 10 Digital Influencers. Additionally, Matt is the host of the well-known Healthcare de Jure podcast.
Niko and Matt covered a lot of ground in this conversation focused on data privacy rights. Here are some of the leading topics.
02:37 – Today’s biggest regulatory and compliance challenges
13:18 – Data blocking and a patient’s right to access
22:28 – Epic’s concerns about the new ONC rules
32:25 – Data sharing with business “associates”
41:55 – De-identifying data – can it ever be done 100%
50:38 – Building a culture of compliance in the decade ahead
Our thanks to Attorney Matthew Fisher for sharing his insights and expertise on healthcare data privacy rights.
#7 Aneesh Chopra Discusses the New Interop Paradigm on the Redox Podcast
Aneesh Chopra is one of the foremost names in healthcare IT today. He was appointed by President Barack Obama to serve as the United States’ first Chief Technology Officer. After his three years as CTO, President Obama hailed his service, saying Chopra’s “legacy of leadership and innovation will benefit Americans for years to come.”
In the years since he served as the nation’s CTO, Chopra has worked tirelessly to promote a better and more efficient healthcare system. Aneesh was one of the four industry leaders that convened the CARIN Alliance in 2016, a bipartisan, multi-sector collaborative working to advance the consumer-directed exchange of health information. He was also part of the founding group that started the Argonaut Project, an effort designed to accelerate the development and adoption of HL7’s Fast Healthcare Interoperability Resources (FHIR®) standard. Chopra authored a book, “Innovative State: How New Technologies can Transform Government.” Currently, Aneesh is president of CareJourney, a healthcare analytics company based in Arlington, Virginia.
Aneesh Chopra and Niko Skievaski covered many important issues in this engaging conversation. Some of the topic highlights can be found at:
02:25 – Aneesh’s service as U.S. CTO
15:12 – The role of government policy in encouraging innovation in healthcare
25:12 – Evolving infrastructure and incentives to promote interoperability
33:54 – Explaining the new rules from CMS
45:11 – Creating the apps that will facilitate consumer and industry adoption of new programs
54:05 – Resources for driving interoperability
Interoperability and open APIs are clearly things that Aneesh Chopra believes will improve patient care and reduce the cost of healthcare. This new interop paradigm will be accomplished sooner if private and public forces work collaboratively in the interest of a better system for all Americans.Our thanks to Aneesh Chopra for joining us on The Redox Podcast.
#6 Pharmacy of the Future with Alto's Mattieu Gamache-Asselin
As patients, the traditional pharmacy business seems to be a mess. It appears to be a jumble of information exchange, insurance contracts, middlemen, generics, phone calls, faxes, cross-subsidies, and misaligned incentives. The process can be frustrating, time-consuming, and expensive. As if that’s not bad enough, it can often result in patients not adhering to their medication routine. Fortunately, there are some creative entrepreneurs working on ways to improve the system. Leading the charge is Alto Pharmacy.
While in the Bay Area for the recent J.P. Morgan Healthcare Conference, Niko Skievaski sat down with Alto’s CEO Mattieu Gamache-Asselin for a lively discussion about the pharmacy of the future. We invite you to enjoy the entire conversation. A few highlights can be found at these times:
02:08 – Matt’s back-end roots working with Parse
06:10 – Buying a pharmacy to really understand both the business and patient needs.
11:10 – Creating the ideal patient experience
20:21 – Alto’s process and how patients realize value
26:43 – New challenges to be solved in the months and years ahead
31:39 – With all the stakeholders in healthcare, is it possible to create value for everyone?
37:11 – Create change “one step at a time”
While Alto is relatively unknown to consumers nationwide today, that’s only because they’ve prudently chosen a disciplined approach to perfecting their new model for pharmacy service. Focusing on select markets allows Alto to prove the economics of their model, discover the most efficient way to operate, and, most importantly, ensure great customer experiences. This strategy will serve them well in the long term and it’s only a matter of time before Alto is a well-known national brand name.
Thank you for listening to this episode of The Redox Podcast.
#5 2019 Review and a Look Ahead to 2020
2019 was another eventful year for both Redox and the healthcare industry. Redox co-founders Luke Bonney, James Lloyd, and Niko Skievaski discuss a wide range of topics from the company’s remarkable progress in its first five years, notable market activity in the year past, and predictions for 2020 and the new decade ahead. Notable parts of the conversation include:
01:26 – The first five years of Redox
08:40 – Tech giants becoming more active in healthcare
13:52 – The advantages of Redox being a remote workplace
19:18 – Helping organizations with digital transformation
22:38 – Prediction for 2020 and the decade ahead
Redox wishes everyone a healthy and prosperous 2020. Thank you for listening to the Redox podcast.
#4 UPenn's Dr. Bill Hanson on The Redox Podcast
Dr. Bill Hanson is Chief Medical Information Officer and Vice President at Penn Medicine and Professor of Anesthesiology and Critical Care at the Hospital of the University of Pennsylvania. His distinguished career spans more than 30 years and he has consistently been a proponent for using technology to improve patient care.
In this episode of The Redox Podcast, Niko Skievaski and Dr. Hanson cover a variety of important topics, including:
03:20 – What worked and didn’t work with EMRs over the last decade
06:57 – Emancipating patient data
12:08 – The new generation of healthcare professionals leveraging data
17:18 – The growing popularity of telemedicine – Penn Center for Connected Care is one of the largest telehealth centers in the country
21:08 – Apps and patient portals, such as myPennMedicine, help engage patients in their care
26:47 – The need for disruption in healthcare
As large technology companies like Google, Microsoft, Apple, and Amazon get attention for their efforts to develop new healthcare products, it’s important to remember the invaluable role academic medical centers play in healthcare’s innovation process. From the extraordinary clinicians in the hospital rooms and labs, to the bright young medical and nursing students, to the interactions with startups, institutions like Penn Medicine are oftentimes the best place to incubate and grow the new ideas that will help shape the future of healthcare.
Thank you for listening to this episode of The Redox Podcast.